MindMaze receives $105 million funding for neurotherapeutics R&D
Hinduja group-backed neurotherapeutics research company MindMaze has secured a $105 million financing round to accelerate its global commercial growth plans, supercharge ongoing research and development and consolidate the clinical development pipeline of its industry-defining digital therapeutic solutions for a wide spectrum of neurological diseases.